Detalhe da pesquisa
1.
Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted Bootstrap.
J Biopharm Stat
; 28(2): 362-381, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934002
2.
Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer.
Prostate
; 77(5): 479-488, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27990667
3.
Comparison of joint modeling and landmarking for dynamic prediction under an illness-death model.
Biom J
; 59(6): 1277-1300, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28508545
4.
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
Cancer Immunol Immunother
; 65(8): 941-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27277816
5.
Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer.
J Urol
; 194(3): 790-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25912492
6.
Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial.
J Urol
; 193(1): 64-70, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066875
7.
Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma.
Cancer
; 120(5): 692-701, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24249435
8.
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.
Cancer
; 120(17): 2684-93, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24802654
9.
Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma.
Invest New Drugs
; 32(1): 188-94, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24318901
10.
The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancer.
Prostate
; 73(16): 1776-85, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24038143
11.
Cigarette smoking and gemcitabine-induced neutropenia in advanced solid tumors.
Oncology
; 85(4): 216-22, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24080957
12.
Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model.
Dig Dis Sci
; 58(11): 3165-77, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23949641
13.
IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin up-regulation.
J Cell Biochem
; 113(5): 1569-80, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22174091
14.
Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium.
Invest New Drugs
; 30(2): 749-57, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21049281
15.
Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies.
Invest New Drugs
; 30(1): 249-57, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20686817
16.
Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma.
World J Surg
; 36(7): 1509-16, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22526034
17.
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.
Invest New Drugs
; 29(6): 1432-40, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20336348
18.
Cross-tolerization between Nod1 and Nod2 signaling results in reduced refractoriness to bacterial infection in Nod2-deficient macrophages.
J Immunol
; 181(6): 4340-6, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18768892
19.
Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
J Urol
; 182(5): 2410-4, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19765742
20.
Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
J Urol
; 182(1): 59-65; discussion 65, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447443